Somalogic Inc (SLGC) - Net Assets
Based on the latest financial reports, Somalogic Inc (SLGC) has net assets worth $496.74 Million USD as of September 2023. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($565.05 Million) and total liabilities ($68.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Somalogic Inc (SLGC) strategic investment index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $496.74 Million |
| % of Total Assets | 87.91% |
| Annual Growth Rate | 201.94% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 343.87 |
Somalogic Inc - Net Assets Trend (2019–2022)
This chart illustrates how Somalogic Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see SLGC stock market capitalisation.
Annual Net Assets for Somalogic Inc (2019–2022)
The table below shows the annual net assets of Somalogic Inc from 2019 to 2022. Also explore SLGC year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $562.56 Million | -8.08% |
| 2021-12-31 | $612.02 Million | +229.19% |
| 2020-12-31 | $185.92 Million | +810.47% |
| 2019-12-31 | $20.42 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Somalogic Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 24971900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $19.00K | 0.00% |
| Other Comprehensive Income | $-513.00K | -0.09% |
| Other Components | $1.17 Billion | 208.18% |
| Total Equity | $562.56 Million | 100.00% |
Somalogic Inc Competitors by Market Cap
The table below lists competitors of Somalogic Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Editas Medicine Inc
NASDAQ:EDIT
|
$396.24 Million |
|
Delcath Systems Inc
NASDAQ:DCTH
|
$396.31 Million |
|
Henan Qingshuiyuan Technology Co Ltd
SHE:300437
|
$396.34 Million |
|
Dhipaya Group Holdings PCL
BK:TIPH-R
|
$396.40 Million |
|
Hefei Gocom Information Technology Co Ltd
SHG:688367
|
$396.21 Million |
|
Hunan Mendale Hometextile Co Ltd
SHE:002397
|
$396.11 Million |
|
Wei Long Grape Wine Co Ltd
SHG:603779
|
$396.04 Million |
|
Kairuide Holding Co Ltd
SHE:002072
|
$395.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Somalogic Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 612,024,000 to 562,558,000, a change of -49,466,000 (-8.1%).
- Net loss of 109,157,000 reduced equity.
- Share repurchases of 5,185,000 reduced equity.
- Other comprehensive income decreased equity by 441,000.
- Other factors increased equity by 65,317,000.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-109.16 Million | -19.4% |
| Share Repurchases | $5.18 Million | -0.92% |
| Other Comprehensive Income | $-441.00K | -0.08% |
| Other Changes | $65.32 Million | +11.61% |
| Total Change | $- | -8.08% |
Book Value vs Market Value Analysis
This analysis compares Somalogic Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.24x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 169.28x to 6.24x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.11 | $19.08 | x |
| 2020-12-31 | $1.03 | $19.08 | x |
| 2021-12-31 | $4.46 | $19.08 | x |
| 2022-12-31 | $3.06 | $19.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Somalogic Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -19.40%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -111.77%
- • Asset Turnover: 0.15x
- • Equity Multiplier: 1.15x
- Recent ROE (-19.40%) is above the historical average (-87.76%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -279.15% | -177.10% | 0.45x | 3.49x | $-59.04 Million |
| 2020 | -38.38% | -127.67% | 0.23x | 1.30x | $-89.94 Million |
| 2021 | -14.10% | -105.73% | 0.12x | 1.15x | $-147.50 Million |
| 2022 | -19.40% | -111.77% | 0.15x | 1.15x | $-165.41 Million |
Industry Comparison
This section compares Somalogic Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $372,273,471
- Average return on equity (ROE) among peers: -131.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Somalogic Inc (SLGC) | $496.74 Million | -279.15% | 0.14x | $396.23 Million |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.51 Million |
| American Well Corp (AMWL) | $-204.41 Million | 0.00% | 0.00x | $133.17 Million |
| Heartbeam Inc (BEAT) | $150.12 Million | 6.13% | 0.10x | $20.27 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $2.59 Million | -206.61% | 0.07x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $784.08 Million | -6.88% | 5.94x | $10.63 Billion |
| Carlsmed, Inc. (CARL) | $98.87 Million | -29.97% | 0.32x | $409.27 Million |
| CareCloud, Inc. (CCLD) | $406.08K | 28.81% | 7.58x | $87.11 Million |
| Certara Inc (CERT) | $492.05 Million | -1.81% | 1.11x | $1.12 Billion |
| CareMax Inc (CMAX) | $61.44 Million | -1112.15% | 9.14x | $381.50 |
| Claritev Corporation (CTEV) | $2.34 Billion | 4.35% | 2.51x | $395.51 Million |
About Somalogic Inc
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in … Read more